⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668050 | 1.00 | — | — | |
| SCHEMBL665223 | 1.00 | — | — | |
| SCHEMBL195917 | 0.81 | — | — | |
| SCHEMBL195918 | 0.81 | — | — | |
| SCHEMBL1579034 | 0.81 | — | — | |
| SCHEMBL554844 | 0.79 | — | — | |
| SCHEMBL146206 | 0.79 | — | — | |
| SCHEMBL5868642 | 0.71 | — | — | |
| SCHEMBL554942 | 0.69 | — | — | |
| SCHEMBL1858589 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118201916-A | Piperazinylsulfonylaryl compounds for the treatment of bacterial infections | 豪夫迈·罗氏有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20240150326-A1 | CARBOXAMIDE COMPOUNDS AND USES THEREOF | INCYTE CORPORATION | 2024-05-09 | — | — | US | claimed |
| US-20240150362-A1 | Substituted Pyrrolotriazines | MOLECURE S.A. (PL) | 2024-05-09 | — | — | US | claimed |
| CN-112292380-B | N- (phenyl) -2- (phenyl) pyrimidine-4-carboxamide derivatives and related compounds as HPK1 inhibitors for the treatment of cancer | 因赛特公司 | 2024-04-05 | — | — | CN | claimed |
| WO-2024042494-A1 | SUBSTITUTED PYRROLOTRIAZINES | MOLECURE SA (PL) | 2024-02-29 | — | — | WO | claimed |
| US-11866426-B2 | Benzothiazole compounds and uses thereof | INCYTE CORPORATION (US) | 2024-01-09 | — | — | US | claimed |
| CN-112204028-B | tetrahydro-1H-pyrazino [2,1-a ] isoindoloquinoline compounds for use in the treatment of autoimmune diseases | 豪夫迈·罗氏有限公司 | 2023-12-29 | — | — | CN | claimed |
| EP-3334710-B1 | COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISORDERS | ALZHEON INC (US) | 2023-10-04 | — | — | EP | claimed |
| EP-3802539-B1 | TETRAHYDRO-1H-PYRAZINO[2,1-A]ISOINDOLYLQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE | HOFFMANN LA ROCHE (CH) | 2023-09-20 | — | — | EP | claimed |
| US-20230219973-A1 | DEUBIQUITINASE INHIBITORS AND METHODS OF USE THEREOF | MOLECURE S.A. (PL) | 2023-07-13 | — | — | US | claimed |
| US-4616019-A | ANTIBIOTIC | ABBOTT LABORATORIES (US) | 1986-10-07 | — | — | US | claimed |
| US-4607032-A | Quino-benoxazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1986-08-19 | — | — | US | claimed |
| EP-0162333-A1 | Quino-benzothiazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-11-27 | — | — | EP | claimed |
| EP-0160284-A1 | Quino-benoxazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-11-06 | — | — | EP | claimed |
| EP-0154780-A1 | Quinoline antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-09-18 | — | — | EP | claimed |
| EP-0153580-A1 | Naphthyridine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-09-04 | — | — | EP | claimed |
| US-4539401-A | Pyridobenzoxazine derivatives useful as antibacterial agents | DAIICHI SEIYAKU CO., LTD. (JP) | 1985-09-03 | — | — | US | claimed |
| US-4535161-A | ANTIBIOTIC, BACTERICIDE | DAIICHI SEIYAKU CO., LTD. (JP) | 1985-08-13 | — | — | US | claimed |
| US-4533663-A | Quino-benzothiazine antibacterial compounds | ABBOTT LABORATORIES (US) | 1985-08-06 | — | — | US | claimed |
| EP-0101829-A2 | Tricyclic compounds, a process for their production and pharmaceutical compositions containing said compounds | DAIICHI SEIYAKU CO., LTD. (JP) | 1984-03-07 | — | — | EP | claimed |